与代谢 (功能障碍) 相关的脂肪肝疾病的治疗:随机对照试验的证据-简要评论
Konstantinos Kitsios1, Christina-Maria Trakatelli1, Christina Antza1
1Third Department of Internal Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.
Metabolic syndrome and related disorders
|August 1, 2024
概括
代谢相关的脂肪肝疾病 (MALFD) 是一种进展性肝脏疾病. 有效的治疗方法包括改变生活方式,减肥手术和某些药物,正在研究新疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 心血管疾病 心血管疾病
背景情况:
- 代谢相关的脂肪肝疾病 (MALFD) 是一种与肥胖和代谢综合征相关的流行和渐进性肝病.
- 它涵盖了一系列的肝脏病理,从简单的肥胖症到肥胖肝炎 (MASH),纤维化,肝硬化和肝细胞癌.
研究的目的:
- 审查目前和新兴的代谢相关脂肪肝疾病的治疗策略.
- 突出生活方式干预,手术方法和药理学剂的有效性.
主要方法:
- 对MALFD治疗的随机试验和临床数据的审查.
- 对饮食,运动,减肥手术和特定药物的证据分析.
- 考虑新兴疗法,如GLP-1受体激动剂和双重激动剂.
主要成果:
- Resmetirom是FDA批准用于MALFD治疗的药物.
- 低热量饮食和运动促进MASH解决.
- 腹部外科手术导致持续的MASH解决和改善肝纤维化.
- 皮奥格利塔可能会在早期阶段解决MASH.
- GLP-1受体激动剂在MASH解决方面表现有前途,但在纤维化方面却没有.
- 提尔泽帕提德和SGLT2抑制剂的初步数据显示令人鼓舞.
结论:
- 改变生活方式和大量减肥对于管理MALFD至关重要.
- 几种药理学药物在MASH解决中表现出有效性,目前正在进行纤维化研究.
- 对于更新的药物,如蒂尔泽帕提德和SGLT2抑制剂,需要通过肝活检进行进一步的研究.
相关概念视频
01:24Overview of Lipid Metabolism
1.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.3K
01:29Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
01:15Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
613
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
613